Home
About Thrombosis
About TRI
Our Research
Patients
Enquiries
GARFIELD
Our Global Reach

Welcome to the Global Anticoagulant Registry in the FIELD

Thromboembolic stroke represents a major challenge and its prevention will be a defining component of population healthcare in the 21st century. The GARFIELD Registry has the potential to enhance the breadth and depth of understanding of stroke prevention in atrial fibrillation and ultimately help to develop strategies for improving patient outcomes worldwide.

The GARFIELD website will introduce you to atrial fibrillation and our academic research programme.

None

GARFIELD Status Update

See the registry's progress through 5 sequential cohorts. Cohort 2 is currently ongoing.

Read more iconClick to read more
None

Steering Committee on Camera

Watch the members of the Steering Committee speak about the importance of the registry

Read more iconClick to read more
ESC a

The challenge of stroke prevention

Watch the presentations from the GARFIELD Satellite Symposium at ESC 2012

Read more iconClick to read more
Global Status
Total Patients: 21814
Current Cohort: 2
Patients in Cohort 2: 11197
Click to read more
Cohort 2 Extended to...

The deadline for entering patients in Cohort 2 has been extended until 31 May

Click to read moreClick to read more
Baseline Paper Publi...

The GARFIELD baseline paper for Cohort 1 has been published in PLOS ONE

Click to read moreClick to read more

If you have forgotten your password or if you are a member of the GARFIELD Community and would like to register for an account, click here.  Send us your name, email address, country and site number.

Contact Us
  • If you would like to contact the study management team click here.